NEWMarkets

Xeris Biopharma (XERS) Beth Hecht Sells $141,434 in Stock

Published on 9/1/2026

#XERS#InsiderTrading#StockSale
Xeris Biopharma (XERS) Beth Hecht Sells $141,434 in Stock

AI Summary

Summarized by AI from the source below

Beth Hecht of Xeris Biopharma (XERS) sold $141,434 worth of company stock. This sale may indicate her views on the company's current valuation or future outlook. Such insider transactions can be significant for investors as they may reflect insider sentiment regarding share performance. Understanding these trades is important for estimating market trends and potential investment decisions.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Xeris Biopharma COO Kevin McCulloch Sells $127,308 in Stock
Earnings

Xeris Biopharma COO Kevin McCulloch Sells $127,308 in Stock

Sep 1

Xeris Biopharma (XERS) CFO Steven Pieper Sells $42,500 in Shares
Markets

Xeris Biopharma (XERS) CFO Steven Pieper Sells $42,500 in Shares

Sep 1

Ani Pharmaceuticals (ANIP) CFO sell $207,480 in stock
Markets

Ani Pharmaceuticals (ANIP) CFO sell $207,480 in stock

Sep 1

Crexendo (CXDO) CTO David Wang Sells $162,500 in Company Stock
Markets

Crexendo (CXDO) CTO David Wang Sells $162,500 in Company Stock

Sep 1